303 related articles for article (PubMed ID: 21455214)
21. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
[TBL] [Abstract][Full Text] [Related]
22. Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway.
Wang EM; Fan QL; Yue Y; Xu L
Med Sci Monit; 2018 Feb; 24():846-854. PubMed ID: 29428962
[TBL] [Abstract][Full Text] [Related]
23. 3,5,3'-triiodothyronine (T3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes.
Gnocchi D; Leoni S; Incerpi S; Bruscalupi G
Steroids; 2012 May; 77(6):589-95. PubMed ID: 22366194
[TBL] [Abstract][Full Text] [Related]
24. Activation of mTOR by human T-cell leukemia virus type 1 Tax is important for the transformation of mouse T cells to interleukin-2-independent growth.
Yoshita M; Higuchi M; Takahashi M; Oie M; Tanaka Y; Fujii M
Cancer Sci; 2012 Feb; 103(2):369-74. PubMed ID: 22010857
[TBL] [Abstract][Full Text] [Related]
25. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.
Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V
Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571
[TBL] [Abstract][Full Text] [Related]
26. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
[TBL] [Abstract][Full Text] [Related]
27. Target of rapamycin signaling in leukemia and lymphoma.
Vu C; Fruman DA
Clin Cancer Res; 2010 Nov; 16(22):5374-80. PubMed ID: 20826559
[TBL] [Abstract][Full Text] [Related]
28. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
Ling Z; Fang ZG; Wu JY; Liu JJ
Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
[TBL] [Abstract][Full Text] [Related]
29. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
[TBL] [Abstract][Full Text] [Related]
30. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.
Burchert A; Wang Y; Cai D; von Bubnoff N; Paschka P; Müller-Brüsselbach S; Ottmann OG; Duyster J; Hochhaus A; Neubauer A
Leukemia; 2005 Oct; 19(10):1774-82. PubMed ID: 16136169
[TBL] [Abstract][Full Text] [Related]
31. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor 1 receptor-mediated cell survival in hypoxia depends on the promotion of autophagy via suppression of the PI3K/Akt/mTOR signaling pathway.
Liu Q; Guan JZ; Sun Y; Le Z; Zhang P; Yu D; Liu Y
Mol Med Rep; 2017 Apr; 15(4):2136-2142. PubMed ID: 28260056
[TBL] [Abstract][Full Text] [Related]
33. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
34. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
35. Neferine from Nelumbo nucifera induces autophagy through the inhibition of PI3K/Akt/mTOR pathway and ROS hyper generation in A549 cells.
Poornima P; Weng CF; Padma VV
Food Chem; 2013 Dec; 141(4):3598-605. PubMed ID: 23993526
[TBL] [Abstract][Full Text] [Related]
36. Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation.
Nagai S; Kurebayashi Y; Koyasu S
Ann N Y Acad Sci; 2013 Mar; 1280():30-4. PubMed ID: 23551100
[TBL] [Abstract][Full Text] [Related]
37. Alpha-crystallin promotes rat olfactory ensheathing cells survival and proliferation through regulation of PI3K/Akt/mTOR signaling pathways.
Wang YH; Li YC; Huo SJ; Yin ZQ
Neurosci Lett; 2012 Dec; 531(2):170-5. PubMed ID: 23142719
[TBL] [Abstract][Full Text] [Related]
38. Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation.
Huang C; Sheng S; Li R; Sun X; Liu J; Huang G
Oncol Rep; 2015 Feb; 33(2):875-84. PubMed ID: 25484022
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia induces adipocyte differentiation of adipose-derived stem cells by triggering reactive oxygen species generation.
Kim JH; Kim SH; Song SY; Kim WS; Song SU; Yi T; Jeon MS; Chung HM; Xia Y; Sung JH
Cell Biol Int; 2014 Jan; 38(1):32-40. PubMed ID: 23956071
[TBL] [Abstract][Full Text] [Related]
40. [Recent studies on PI3K/AKT/mTOR signaling pathway in hematopoietic stem cells].
Zhang YC; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):245-9. PubMed ID: 23484729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
